Ignite Creation Date:
2024-05-06 @ 8:07 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06267560
Status:
RECRUITING
Last Update Posted:
2024-02-20
First Post:
2024-02-12
Brief Title:
Lpa Lowering Study of Pelacarsen TQJ230 in US BlackAfrican American and Hispanic Participants With Elevated Lpa and Established ASCVD
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-27
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-06-21
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-06-21
Completion Date Type:
ESTIMATED
First Submit Date:
2024-02-12
First Submit QC Date:
February 12 2024
Study First Post Date:
2024-02-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-27
Last Update Post Date:
2024-02-20
Last Update Post Date Type:
ACTUAL